Tectonic Therapeutic, Inc.
TECX
$32.80
-$0.51-1.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -55.39% | -7.44% | -57.71% | -4.50% | -57.24% |
| Total Depreciation and Amortization | -34.45% | -19.34% | 1.19% | -4.51% | 36.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 445.83% | 75.94% | 41.67% | -2.83% | 258.44% |
| Change in Net Operating Assets | 115.97% | 39.87% | 153.35% | -105.24% | -49.36% |
| Cash from Operations | 14.03% | 9.13% | -9.99% | -41.09% | -44.30% |
| Capital Expenditure | 100.00% | -18.30% | -100.00% | -575.00% | 94.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -8.50% | 1,275.00% | -575.00% | 94.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.43% | -2.50% | 0.82% | 0.00% | 0.00% |
| Issuance of Common Stock | -93.44% | -92.21% | -91.82% | 4,455,900.00% | -97.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 96.06% | 94.55% | -114.50% | -- | -- |
| Cash from Financing | 86.81% | 92.73% | -102.32% | 26,764.97% | -103.13% |
| Foreign Exchange rate Adjustments | -194.59% | -253.33% | -300.00% | 93.42% | 131.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.03% | 29.08% | -111.34% | 1,746.61% | -179.58% |